The role of E2-2 in the development and function of plasmacytoid dendritic cells
E2-2在浆细胞样树突状细胞发育和功能中的作用
基本信息
- 批准号:7546392
- 负责人:
- 金额:$ 4.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AntigensAutoimmune DiseasesBHLH ProteinCell LineageCellsCharacteristicsDendritic CellsDevelopmentDiseaseE proteinGene ExpressionGene TargetingGeneticGenomeHandHyperactive behaviorImmuneImmune responseImmune systemInterferon Type IInterferonsMaintenanceMolecularMolecular ProfilingMusNamesNucleic AcidsPDC genePathway interactionsPatternPersonal SatisfactionPlayPsoriasisPublic HealthResearch Project GrantsRoleSatellite VirusesSystemic Lupus ErythematosusUpper armViralVirusVirus Diseasesbasechromatin immunoprecipitationinsightnovel strategiesphosducinprogramsresponsetranscription factor
项目摘要
DESCRIPTION (provided by applicant): Plasmacytoid dendritic cells (pDCs) represent a unique immune cell lineage that plays an essential role in innate immune responses against viruses. pDCs recognize virus-associated nucleic acids and respond by rapidly secreting massive amounts of type I interferons (IFN), hence their other name: type I interferon- producing cells (IPCs). pDCs can also differentiate, upon activation, into conventional dendritic cells that are capable of presenting antigens to the adaptive arm of the immune system. Thus, pDC are critical for the body's control of viral infections. On the other hand, abnormal pDC hyperactivity has been associated with increased type I IFN levels in autoimmune diseases such as psoriasis and systemic lupus erythematosus. Therefore, pDCs do play important roles in both normal and aberrant immune responses and represent potential useful targets in the treatment of some diseases. pDCs possess unique cellular and molecular characteristics and gene expression profiles that enable them to directly recognize viruses, secrete massive amounts of type I IFN, and differentiate into conventional dendritic cells. Over the last few years, these molecular and cellular features of pDCs have been well characterized; however, the genetic basis of pDC lineage commitment, maturation, and function still remains poorly understood. The overall objective of our research project is to study the role of basic helix-loop-helix transcription factors in the development and function pDCs, and elucidate the pathways that these transcription factors control in pDCs. PUBLIC HEALTH RELEVANCE: These studies will give us insights into the genetic network which controls the development and function of pDC, and may pave the way for the development of new approaches in the treatment of viral infections and some autoimmune disease.
描述(申请人提供):浆细胞样树突状细胞(pDC)代表一种独特的免疫细胞谱系,在抗病毒的先天免疫应答中发挥重要作用。pDC识别病毒相关核酸并通过快速分泌大量的I型干扰素(IFN)来应答,因此它们的另一个名称为:I型干扰素产生细胞(IPC)。pDC还可以在活化后分化成能够将抗原呈递给免疫系统的适应性臂的常规树突细胞。因此,pDC对于身体控制病毒感染至关重要。另一方面,异常pDC过度活跃与自身免疫性疾病如银屑病和系统性红斑狼疮中I型IFN水平的增加有关。因此,pDC在正常和异常免疫应答中发挥重要作用,并在一些疾病的治疗中代表潜在的有用靶标。pDC具有独特的细胞和分子特征以及基因表达谱,使它们能够直接识别病毒,分泌大量的I型IFN,并分化为常规的树突状细胞。在过去的几年中,pDC的这些分子和细胞特征已经得到了很好的表征;然而,pDC谱系定型、成熟和功能的遗传基础仍然知之甚少。本课题的总体目标是研究碱性螺旋-环-螺旋转录因子在pDC发育和功能中的作用,并阐明这些转录因子在pDC中调控的途径。公共卫生相关性:这些研究将使我们深入了解控制pDC发育和功能的遗传网络,并可能为开发治疗病毒感染和某些自身免疫性疾病的新方法铺平道路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Babacar Cisse其他文献
Babacar Cisse的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Babacar Cisse', 18)}}的其他基金
The role of E2-2 in the development and function of plasmacytoid dendritic cells
E2-2在浆细胞样树突状细胞发育和功能中的作用
- 批准号:
7666056 - 财政年份:2008
- 资助金额:
$ 4.6万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Operating Grants
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Biomarkers of vascular endothelial dysfunction in systemic autoimmune diseases: analysis of circulating microRNAs
系统性自身免疫性疾病中血管内皮功能障碍的生物标志物:循环 microRNA 分析
- 批准号:
23K14742 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Structural mechanisms of autoimmune diseases targeting cys-loop receptors
针对半胱氨酸环受体的自身免疫性疾病的结构机制
- 批准号:
10864719 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
免疫治疗引起的自身免疫性疾病的新型体液和细胞生物标志物
- 批准号:
10593224 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Regulation of autoimmune diseases by PTPN22 phosphatase
PTPN22磷酸酶对自身免疫性疾病的调节
- 批准号:
23K06589 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases
破译并靶向自身免疫性疾病中的 GABA 代谢和 GABA 受体介导的信号传导
- 批准号:
10623380 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别:
Targeting the long isoform of the prolactin receptor to treat autoimmune diseases and B-cell malignancies
靶向催乳素受体的长亚型来治疗自身免疫性疾病和 B 细胞恶性肿瘤
- 批准号:
10735148 - 财政年份:2023
- 资助金额:
$ 4.6万 - 项目类别: